杜皮鲁玛
医学
嗜酸性食管炎
内科学
皮肤病科
单克隆抗体
单克隆
免疫学
抗体
特应性皮炎
疾病
作者
Evan S. Dellon,Marc E. Rothenberg,Margaret H. Collins,Ikuo Hirano,Mirna Chehade,Albert J. Bredenoord,Alfredo J. Lucendo,Jonathan M. Spergel,Seema S. Aceves,Xian Sun,Matthew P. Kosloski,Mohamed Kamal,Jennifer D. Hamilton,Bethany Beazley,Eilish McCann,Kiran Patel,Leda Mannent,Elizabeth Laws,Bolanle Akinlade,Nikhil Amin
标识
DOI:10.1056/nejmoa2205982
摘要
Among patients with eosinophilic esophagitis, subcutaneous dupilumab administered weekly improved histologic outcomes and alleviated symptoms of the disease. (Funded by Sanofi and Regeneron Pharmaceuticals; ClinicalTrials.gov number, NCT03633617.).
科研通智能强力驱动
Strongly Powered by AbleSci AI